Introduction
Atrial fibrillation (AF), one of the most common cardiac arrhythmias, is associated with 15 -20% of all ischaemic strokes. 1 Recent studies have shown that, in non-valvular atrial fibrillation (NVAF), 90% of cardiac thrombi are located in the left atrial appendage (LAA). 2 LAA occlusion (LAAO) has emerged as a valid alternative in patients with a formal contraindication to oral anticoagulant (OAC) therapy. 3 The most widely used devices are the Watchman (Boston Scientific, MN, USA) and the Amplatzer Cardiac Plug (ACP, St Jude Medical, MN, USA). As shown in PROTECT AF, LAAO with the Watchman device was non-inferior to warfarin treatment for all the primary endpoints (cardiovascular death, stroke, and systemic embolization). 4 Favourable results, emerging from registries, have also been published for the ACP. 5 -9 Percutaneous LAAO is now included in the updated ESC guidelines for AF (Class IIb, Level B). 3 Anatomical knowledge of LAA morphology is particularly important for pre-procedural planning. In fact, the selection of appropriate device size for implantation is a major factor for a successful intervention. Accurate measurements of the LAA are critical for the sizing of these devices, and current protocols typically use transoesophageal echocardiography (TEE). Invasive imaging modalities such as TEE or intracardiac echocardiography (ICE) and conventional cardiac angiography (CCA) have certain obvious advantages over three-dimensional (3D) non-invasive techniques, such as multidetector computed tomography (MDCT), due to their ability to give real-time images, which are very helpful in the catheterization laboratory. However, 3D techniques may provide additional qualitative and quantitative information not otherwise available, such as high spatial resolution and a detailed 3D and four-dimensional (4D) assessment of intracardiac structures. Thanks to these advantages the MDCT is gradually gaining ground in clinical practice in preand postoperative evaluation of LAAO through cardiac computed tomography angiography (CCTA).
The size selection is not a simple issue, due to the high variability in the anatomical shape of the LAAs 10 and to the variable information that different imaging techniques provide for the diameter measurement. In recent studies, a device size different from the one actually needed had been preselected in a percentage of cases variable from 17 to 24%. 11, 12 Although the available imaging techniques are of good value, the data obtained using different methods may not match, thereby potentially not facilitating the task of choosing the correct size. The main two measures used to choose the correct size of the occluder devices are the diameters of the LAA 'ostium' (OS) for the selection of the Watchman device, and 'landing zone' (LZ) for the selection of the ACP device, through consultation of the manufacturers' sizing charts.
The aim of our study was to compare the pre-and intraprocedural imaging techniques in patients with NVAF in determining the correct selection of the device size for LAAO, with a retrospective evaluation of the results obtained at post-procedural CCTA.
Methods

Study design
In this retrospective single-centre study, 66 consecutive patients underwent preoperative planning of LAAO between September 2009 and July 2013. All the patients had NVAF with contraindication to OAC therapy (Chads2Vasc 4.35 + 1.26; Has-Bled 3.51 + 1.04; mean age 78 + 6 years). The procedure was performed with the Amplatzer Cardiac Plug device. Post-procedural CCTA was performed on 58 of 66 patients to assess LAAO outcome.
Written informed consent was obtained from all patients, and the study protocol was approved by the Institutional Ethics Committee.
Preoperative measurements of the LAA were carried out and compared with TEE, CCTA, ICE, and CCA.
At post-procedural examinations, the number and extent of the residual leaks and the positioning of the device was assessed with CCTA.
Prior to the device implantation, extensive imaging modalities were performed to determine the LAA OS and LZ diameters, to exclude LAA thrombosis, and to explore the atrial and appendage anatomy in determining the appropriate device size.
In the 'pre-procedural phase', TEE and CCTA were used for the correct measurement of the LAA (OS and LZ), to define the size and the shape of the LAA as well as to rule out the presence of thrombi.
TEE sizing
TEE was performed with the patient under conscious sedation (e.g. midazolam 2 -5 mg) documenting the absence of thrombi within the LAA, determining the OS and LZ diameters, shape, number of lobes, location, working length in the LAA, and pectinate features. Two-dimensional (2D) TEE measurements were obtained by a mid-oesophageal window with three projections: at 458, 908, and 1358; the final LZ diameters were calculated from the average of the three results. The measure performed at the level of the OS was taken from the left circumflex artery to the tip of the left upper pulmonary vein and at the level of the LZ 1 cm distal to the OS ( Figure 1A ).
CCTA scan parameters
Both pre-and post-procedural CCTA scans were performed with the same protocol. The examinations were performed by using a 64-or 320-detector scanner, with a multiphasic acquisition. Iodinated contrast medium (iopromide, Ultravist 370, Bayer SpA, Germany, 70 -90 mL) was administered through an antecubital vein (flow rate: 5 mL/s), followed by 50 mL of saline chaser bolus (sodium chloride 0.9%), administered at the same flow rate. The dose modulation was used when possible. A first angiographic acquisition was acquired with retrospective ECG-gating. A second prospective scan of 4-8 cm (40% R-R), targeted at the LAA, was performed after 40 s. After ECG editing (when necessary), axial images were reconstructed with the following parameters: 'best-phase' of the R-R interval (mid-to-late diastolic phase) and 75% with slice Multimodality imaging approach to LAA occlusion with ACP thickness 0.5 mm, increment 0.25 mm; 0-90% of the RR interval at 10% increments (slice thickness 1 mm and increment 1 mm) to evaluate cardiac morphological and functional changes.
CCTA sizing
The LAA was evaluated with CCTA identifying first the phase of maximum LAA expansion and then the correct OS and LZ planes with multiplanar reconstruction (MPR) images.
From the axial acquisition images, a two-chamber long-axis projection was obtained showing the long axis of the left ventricle as well as the left appendage. From the latter, placing the cross-sectional axis at the level of the base of the LAA, rotating it to align with both the ligament of Marshall and the circumflex artery, a third projection was identified where the LAA OS was viewable (Figure 2A and B) . This oval image, limited by the ligament of Marshall and circumflex artery, allowed to determine the morphology and the size of LAA OS.
The LZ plane was detected as a plane between a point 10 mm distal to the centre of the OS on the midline and the circumflex artery, perpendicular to the long axis of LAA neck ( Figure 2B) .
To evaluate interobserver variability with CCTA, two blind operators measured the mean diameter between the maximum diameter and its orthogonal (d M ) and the diameter taken from the area (d A ) in a subgroup of patients.
The diameter taken from the area (d A ) was then used as CCTA diameter.
ICE sizing
All implantation procedures were performed with ICE monitoring. The ICE probe was positioned in the right atrium (RA) or in the coronary sinus (CS). The ICE catheter, placed within the RA, allowed the visualization of the left atrial anatomy, as well as the OS and LZ of the LAA. ICE was also used to assess the diameter of the LAA by measuring the transverse diameter 10 mm below the OS ( Figure 1B) . These measurements were compared with those previously obtained by TEE and with those chosen by angiography measured by a different operator.
CCA sizing
Left atrium and appendage angiography were performed, and the OS and LZ diameters were measured using two different projections The occluder device size was selected using CCA measures keeping into account the other techniques.
Post-procedural CCTA dataset analysis
Post-procedural CT was performed at 5.2 + 4.6 months in 58 patients. On post-procedural datasets, complete exclusion of the LAA or the presence of any leak was evaluated. Regarding the presence of leaks, a semi-quantitative CCTA classification was used:
(i) No leak (NL): absence of LAA opacification in the delayed phase ( Figure 4A ). (ii) High-flow leak (HFL): opacification of more than one-third of the appendage in the arterial phase ( Figure 4B ). (iii) Low-flow leak (LFL): appendage opacification in the venous phase/ opacification of less than one-third of the appendage in the arterial phase ( Figure 4C and D).
In addition, the correct positioning of device, the possible angle of the device relative to the plane of the LZ and the morphology assumed by the lobe were evaluated.
To determine the correct positioning of the device the following criteria were used:
(i) Optimal placement (OP): lobe of the device placed at the level of the LZ ( Figure 5A ).
(ii) Angled placement (AP): lobe of the device placed at the level of the LZ with its axis perpendicular to the lobe diverging from the plane of the LZs ( Figure 5B ). (iii) Suboptimal placement (SOP): lobe of the device with distal positioning to the LZ ( Figure 5C ).
Finally, regarding the morphology of the lobe, the same classification used by Park 13 was used. The lobes of the devices were divided into three classes, depending on the form:
(i) 'Strawberry': excessive deformation of the lobe ( Figure 6A ).
(ii) 'Square': low deformation of the lobe ( Figure 6B ).
(iii) 'Tire': optimal deformation of the lobe ( Figure 6C ).
Role of CCTA in the choice of the device
On the basis of the comparison between the size of the device used for LAAO (u-dev), selected from all data available from TEE, ICE, and CCA imaging techniques, and the size of the device that would have been used through the appropriate sizing chart ( Table 1) 13 only based on measurements obtained with CCTA (ct-dev), three subgroups were identified: u-dev.ct-dev, u-dev¼ct-dev, u-dev,ct-dev. The distribution of the leaks, the correct positioning of the device, and the angulation of the lobe were evaluated in the three subgroups. 
Statistical analysis
Continuous variables are expressed as mean (+SD). The variability of the diameters of the LZ measured with TEE, CCTA, ICE, and CCA techniques was assessed with Pearson's r test. Differences between groups in the distribution of leaks, positioning of the device, and angulation of the lobe were compared using a Likehood ratio test. Significance was set at P , 0.01. ROC analysis was performed for each method to evaluate the predictive value of the difference between the imaging-derived size and the device size used (D) for post-procedural leaks.
Results
LAA filling defects were evidenced in the angiographic phase in 29 patients. The delayed venous phase excluded the presence of thrombosis in all cases. The sizing of the LAA with CCTA was performed in all 66 preprocedural datasets. Measures with other imaging techniques were The size of the device is chosen on the basis of the LZ diameter, with an oversizing variable from 1.4 to 3.5 mm to ensure a stable positioning of the lobe.
available with TEE in 54 cases, with CCA in 57 cases, and with ICE in 40 cases. The diameters of the LZ were collected with all imaging modalities in 34 cases. The average values obtained are presented in Table 2 . The agreement between the device suggested by TEE, CCTA, ICE, CCA, and the device used was calculated ( Table 3) . The operators showed a tendency to be more confident with CCA measures (agreement of 50%).
The Pearson's correlation coefficient (PCC) between the measures of the LZ with the different methods ( Figure 8) is:
(i) r ¼ 0.756 between CCTA and CCA (P , 0.01- Figure 8A) ; (ii) r ¼ 0.712 between CCTA and ICE (P , 0.01- Figure 8B) ; (iii) r ¼ 0.571 between CCTA and TEE (P , 0.01- Figure 8C) ; (iv) r ¼ 0.823 between CCA and ICE (P , 0.01- Figure 8D) ; (v) r ¼ 0.595 between CCA and TEE (P , 0.01- Figure 8E) ; (vi) r ¼ 0.502 between ICE and TEE (P , 0.01- Figure 8F) . Multimodality imaging approach to LAA occlusion with ACP
The distribution of the lobe morphology in 28 cases of OP devices is summarized in Table 6 . There are no significant differences between u-dev.ct-dev and u-dev¼ct-dev in the frequency of leaks and positioning of the device. There is a significant difference between u-dev./¼ct-dev and u-dev,ct-dev for the distribution of leaks (HFL: 27.9 vs. 66.7%; P , 0.01), for an SOP of the device (SOP: 20.9 vs. 53.3%), and for angled device (AP: 25.6 vs. 13.3%; P , 0.01).
ROC analysis results performed in 31 patients for the predictive value of post-procedural leaks ( Figure 9 ): A moderate accuracy to predict the leak is evident both with CT and with ICE. However, the small size of the sample requires further investigation.
Discussion Methods correlation
There is a good correlation between CCTA and both ICE and CCA measures; these last two methods have the highest intermethod correlation; however, it is necessary to take into account a possible bias due to the fact that both measures are taken in the catheterization laboratory during the procedure, with a possible mutual influence of operators. TEE seems to have a lower correlation with all the other methods.
From the average of the diameters of the 34 selected cases, it is shown that TEE is the method with the smallest average diameter, with a likely tendency to underestimate, whereas on the other hand, CCTA is the method with the greatest average diameter. ICE and CCA are in an intermediate position, with the highest inter-method correlation. From these data, a tendency to overestimate of the CCTA may be assumed. However, unlike the other methods, in the CCTA datasets, the phase of maximum LAA expansion was sought, and this justifies, at least in part, the higher average values of the diameters measured. Furthermore, given the ellipsoid nature of OS and LZ lumen, the sizing of LAA using a 3D method should provide greater accuracy than the 2D methods, which could significantly underestimate the size if the imaging plane is not oriented to the largest diameter (Figures 10 and 11) .
Role of CCTA in the choice of the device
By analysing the positioning of the device in the post-procedural CCTA, some observations can be expressed:
(i) the positioning of the lobe of the device distal to the LZ (SOP)
implies an inability to anchor the same and therefore an undersizing of the device;
. The distribution of the high-flow leaks (HFL), low-flow leaks (LFL), and absence of leak (NL) was researched in three different groups where the device implanted (u-dev) was bigger, equal, or smaller than the device suggested by CCTA measurements (ct-dev).
. The distribution of optimal placed (OP), angled placed (AP), and suboptimal placed (SOP) devices was researched in three different groups where the u-dev was bigger, equal, or smaller than the ct-dev. The distribution of lobe morphology on 28 optimal positioned (OP) devices was researched in three different groups where the u-dev was bigger, equal, or smaller than the ct-dev.
(ii) an angulated position of the lobe at the level of the LZ (AP) could be due either to an oversizing of the device or to a procedural difficulty due to the anatomy and the angle at which the catheter is positioned in the LAA, an angle that may limit the optimal positioning of the lobe; and (iii) regarding the OP device, maintaining into account the morphologies of the lobe already described by Park, 13 we can consider a 'squared' lobe morphology as a sign of undersizing, a 'tired' lobe morphology as an optimal sized lobe, and a 'strawberry' lobe morphology as a sign of excessive oversizing.
The u-dev,ct-dev group deviates significantly from the other two groups both for the distribution of leak (HFL: 66.7 vs. 30.4% of u-dev.ct-dev and 25% of u-dev¼ct-dev) and the number of SOP devices (53.3 vs. 17.4% of u-dev.ct-dev and 25% of u-dev¼ct-dev), which are positioned distal to the LZ. Regarding the lobe morphology of the OP, non-angled devices and a 'squared' lobe morphology were detected in 20% of u-dev,ct-dev vs. 8.7% of u-dev.ct-dev and 5% of u-dev¼ct-dev.
Both the SOP device and 'square' lobe morphology can be considered signs of an undersizing of the device. Analysing the overall device with signs of undersizing (SOP and 'square' lobe) in the three groups, there is a 73.3% of u-dev,ct-dev vs. 26.1% of u-dev.ct-dev and 30% of u-dev¼ct-dev.
The absence of significant differences between u-dev.ct-dev and u-dev¼ct-dev may be interpreted in this context as a degree of tolerance of the oversizing of the device, which would not affect the final outcome of the procedure. The only device with sure signs of excessive oversizing ('strawberry' lobe morphology) is located in the u-dev.ct-dev group, and is also associated with LFL. In this perspective, it should be kept in mind that the same developer, on the basis of the experience with ACP 1, recommends an increased oversizing with the Amulet device (from 1.5 -3 mm of oversizing with ACP 1 to 3-6 mm of oversizing with ACP 2).
In view of these considerations, it is therefore reasonable to assume that a choice of the size of the device driven by pre-procedural CCTA would greatly reduce the HFL encountered in this series.
Comparison with the literature
According to early clinical experiences with LAAO, an adequate device size tends to be 20 -40% larger in diameter than predicted by TEE.
14 This finding reinforces the hypothesis given by our experience of a tendency of TEE to underestimate LAA measurements. Regarding the comparison between invasive imaging methods, inter-method correlation of TEE, ICE, and CCA has been evaluated in a dual-centre study by Berti et al. 15 In a comparison on LZ diameters measured using the three methods on 51 patients, the correlation found with the PCC was r ¼ 0.94 between CCA and ICE, and r ¼ 0.72 between TEE and ICE. The patients evaluated in our study are included in the afore-mentioned dual-centre study population, and the different r-values between ICE and TEE at the level of the LZ result from the different time of the enrolment and operator confidence with these imaging methods. Few studies reported in the literature evaluated the correlation between CCTA and the invasive imaging techniques; moreover, the methods of LAA sizing with CCTA datasets were different, and an interpretation of results is difficult. The three main methods described in literature are the measure of diameters with 2D-MPR on standard planes ('axial', 'coronal', and 'sagittal planes'), 2D-MPR on oblique plans using a plan perpendicular to the main axis of OS/LZ, and volume rendering (VR). These three methods have been analysed in a study by Wang et al. 16 three methods, 45.9% between TEE and MDCT, 35.1% between CCA and CCTA, and 24.3% between TEE and CCA. PCC was: r ¼ 0.87 between CCA and TEE, and r ¼ 0.77 between MDCT (superior-inferior diameter) and CCA. The superior-inferior diameter by MDCT showed the highest percentage of agreement with the appropriate device size (75%), with a tendency to overestimate diameters in the cases of disagreement, while in the cases of disagreement between the 2D methods TEE had a tendency to equally over and underestimate diameters, while CCA had a tendency to underestimate.
Blendea et al. 18 compared ICE and MDCT/MR measurements of OS on 21 patients. ICE measurements were made in the CS, in the middle RA, and in the left atrium. The inter-method correlation between ICE and 3D methods was related to the location of the probe: PCC was high with the probe in the left atrium (r ¼ 0.74), lower with the probe in the CS (r ¼ 0.37), and in the RA (r ¼ 0.41). Finally, Krishnaswamy et al., 19 in a study on LAA measurements with CCTA (2D oblique MPR) and TEE in a population of 22 patients, found low correlation between the two methods.
Limitations of the study
There is an absence of a clear 'gold standard' for sizing the LAA because even direct measurements, such as during surgery or postmortem analysis, are likely to underestimate true in vivo LAA size. Starting from this assumption, it was not possible to determine which method could provide more precise LAA diameters. The absence of leaks has been taken into analysis as a possible indicator of LAAO success and therefore of correct selection of the device. However, the angle between the fossa ovalis and LAA and the appendage morphology, such as the neck length and the number of lobes, are other possible parameters that may influence the presence of leaks and they are not taken into account in this study. A 3D TEE technique has not been evaluated in this analysis and future comparisons should be performed.
Conclusions
In the evaluation of LAA dimensions in determining the correct device, CCTA identifies the phase of greater LAA expansion and Figure 11 'Orientation of the angiographic projections on CCTA MPR planes: RAO 408 CAU 208'-angiographic projection on 3D VR (D); orientation of the LAA on the four-chamber axial view (A), two-chamber long-axis view (B), and two-chamber short-axis view (C). The diameter measured in this angiographic projection corresponds to the yellow line on the four-chamber view and diverges from the larger diameter of the LAA oval lumen.
provides a good correlation with intraprocedural imaging techniques (CCA and ICE), whereas TEE has a lower correlation with every other imaging method.
From the average of the diameters obtained with the different methods, LAA diameters measured with CCTA are sized slightly larger than the others, whereas TEE has a likely tendency to underestimate the diameters.
Analysing the presence of the distribution of the leaks and the positioning of the device in post-procedural CCTA, there is a substantial difference between the group in which the device used is smaller than the one selected with CT and the groups in which the device used is equal to or greater than the one selected with CT. Further investigations are required to understand the evolution and clinical significance of post-procedural leaks.
In conclusion, the sizing of the left appendage evaluated with CCTA seems to reduce the risk of high-flow leaks and placement problems of the device related to undersizing. The risk of possible oversizing, which cannot be totally excluded, however, does not seem to interfere with the overall success of the procedure.
CCTA appears to be a practical and concrete method in determining the size of the LAA occluder device to implant and in identifying eventual possible collateral findings.
